APAF1 and renal cell carcinoma: Christoph et al. [27] in their study on methylation of DAPK-1 and APAF-1 and effects of demethylating agents in kidney cancer examined 80 RCC patient samples of clear cell tumors and 20 normal kidney samples from other patients.